Skip to main content

Table 2 Demographic and clinical features of the patients included in the study: Serum samples

From: Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis

 

Disease

Number of patients

Age (Mean ± SD)

Gender

Validation

RRMS

56

35.5 ± 11.2

14M; 42F

INF

53

46.7 ± 16.1

17M; 36F

N-INF

58

51.3 ± 12.7

23M; 35F

  1. M male, F female, RRMS Relapse–remitting multiple sclerosis, INF other inflammatory diseases of the CNS, N-INF non-inflammatory diseases of the CNS
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094